Investigational Drugs and Health Updates
19/06/2026
Investigational Apitegromab Investigational apitegromab, a selective myostatin activation inhibitor, effectively preserved lean mass when combined with tirzepatide (Zepbound) in a
Aprobación de un nuevo parche de terapia hormonal genérico Recentemente, la FDA aprobó el primer genérico del sistema transdérmico de…
Read more →
Investigational Apitegromab Investigational apitegromab, a selective myostatin activation inhibitor, effectively preserved lean mass when combined with tirzepatide (Zepbound) in a
The first dedicated U.S. guideline for cardiovascular-kidney-metabolic (CKM) syndrome makes a big push to unite primary and specialty care in
Resumen de Confianza en CDC Only 50% of the public said they now trust health recommendations from the CDC, down
FDA Updates Orlistat Warnings The FDA issued a drug safety communication approving a label change that warns about the risk
Harvard Professor Passes Away Harvard University professor Robert Coles, MD, the psychiatrist and Pulitzer Prize-winning author who championed the cause